Related Experiment Videos
Power Doppler imaging: initial evaluation as a screening examination for carotid artery stenosis.
E I Bluth1, J H Sunshine, J B Lyons
1Dept of Radiology, Ochsner Foundation Hosp, New Orleans, LA 70121-2484, USA.
Radiology
|June 1, 2000
Summary
Power Doppler imaging shows promise as an accurate and cost-effective screening tool for carotid artery stenosis in asymptomatic individuals. This method offers comparable performance to established screening examinations, suggesting its potential utility in clinical practice.
Area of Science:
- Vascular Ultrasound
- Medical Imaging
- Diagnostic Technology
Background:
- Carotid artery stenosis poses a significant risk for stroke.
- Accurate screening methods are crucial for early detection and intervention.
- Existing screening methods have limitations in accessibility or cost.
Purpose of the Study:
- To assess the efficacy of power Doppler imaging as a screening tool for carotid artery stenosis.
- To compare power Doppler imaging with established diagnostic methods.
- To evaluate the cost-effectiveness of power Doppler imaging for screening.
Main Methods:
- Prospective, blinded comparison of power Doppler imaging against duplex Doppler imaging (reference standard) in 100 patients.
- Validation study comparing power Doppler imaging with digital subtraction angiography (reference standard) in 20 patients.
- Cost-effectiveness analysis was performed using conservative assumptions.
Main Results:
- Power Doppler imaging yielded diagnostic-quality images in 89% of patients.
- The area under the receiver operating characteristic curve (A(z)) was 0.87, with 70% sensitivity and 91% specificity.
- Cost-effectiveness was estimated at $47,000 per quality-adjusted life-year.
Conclusions:
- Power Doppler imaging demonstrates an A(z) value comparable to mammography and other accepted screening examinations.
- The technique is considered a reasonably accurate and cost-effective screening option for carotid artery stenosis.
- This imaging modality holds potential for screening asymptomatic populations at risk for stroke.